Final Overall Survival results from the NICE-NEC trial (GETNE-T1913). A phase II study of nivolumab and platinum-doublet chemotherapy (CT) in untreated advanced G3 Neuroendocrine Neoplasms (NENs) of gastroenteropancreatic (GEP) or unknown (UK) origin
Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Final Overall Survival results from the NICE-NEC trial (GETNE-T1913). A phase II study of nivolumab and platinum-doublet chemotherapy (CT) in untreated advanced G3 Neuroendocrine Neoplasms (NENs) of gastroenteropancreatic (GEP) or unknown (UK) origin ### Output: Nivolumab